{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T13:54:02Z","timestamp":1783518842958,"version":"3.55.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-87678-1","type":"journal-article","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T14:19:35Z","timestamp":1737728375000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Pharmacovigilance imbalance analysis of VEGFR-TKI-related taste and smell disorders"],"prefix":"10.1038","volume":"15","author":[{"given":"Zhong-hua","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenglong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,24]]},"reference":[{"issue":"4","key":"87678_CR1","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1083\/jcb.129.4.895","volume":"129","author":"T Mustonen","year":"1995","unstructured":"Mustonen, T. & Alitalo, K. Endothelial receptor tyrosine kinases involved in angiogenesis. J. Cell. Biol. 129 (4), 895\u2013898 (1995).","journal-title":"J. cell. Biology May"},{"issue":"1","key":"87678_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11912-002-0043-x","volume":"4","author":"S Goel","year":"2002","unstructured":"Goel, S., Mani, S. & Perez-Soler, R. Tyrosine kinase inhibitors: A clinical perspective. Curr. Oncol. Rep. Jan. 4 (1), 9\u201319 (2002).","journal-title":"Curr. Oncol. Rep. Jan"},{"issue":"8","key":"87678_CR3","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1007\/s00432-021-03521-w","volume":"147","author":"W Hou","year":"2021","unstructured":"Hou, W. et al. Comparative evaluation of cardiovascular risks among nine FDA-approved VEGFR-TKIs in patients with solid tumors: A bayesian network analysis of randomized controlled trials. J. Cancer Res. Clin. Oncol. 147 (8), 2407\u20132420 (2021).","journal-title":"J. cancer Res. Clin. Oncol. Aug"},{"issue":"41","key":"87678_CR4","doi-asserted-by":"publisher","first-page":"67661","DOI":"10.18632\/oncotarget.11813","volume":"11","author":"B Liu","year":"2016","unstructured":"Liu, B. et al. Incidence and risk of hypertension associated with vascular endothelial growth factor receptor tyrosine kinase inhibitors in cancer patients: A comprehensive network meta-analysis of 72 randomized controlled trials involving 30013 patients. Oncotarget. 11 (41), 67661\u201367673 (2016).","journal-title":"Oncotarget Oct."},{"issue":"5","key":"87678_CR5","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.ctrv.2014.02.004","volume":"40","author":"T Funakoshi","year":"2014","unstructured":"Funakoshi, T., Latif, A. & Galsky, M. D. Safety and efficacy of addition of VEGFR and EGFR-family oral small-molecule tyrosine kinase inhibitors to cytotoxic chemotherapy in solid cancers: A systematic review and meta-analysis of randomized controlled trials. Cancer Treat. Rev. 40 (5), 636\u2013647 (2014).","journal-title":"Cancer Treat. Reviews Jun"},{"issue":"12","key":"87678_CR6","doi-asserted-by":"publisher","first-page":"4077","DOI":"10.1007\/s00520-018-4277-z","volume":"26","author":"J Amezaga","year":"2018","unstructured":"Amezaga, J. et al. Assessing taste and smell alterations in cancer patients undergoing chemotherapy according to treatment. Support. Care Cancer Off. J. Multinational Assoc. Support. Care Cancer 26 (12), 4077\u20134086 (2018).","journal-title":"Supportive care cancer: Official J. Multinational Association Supportive Care Cancer Dec."},{"key":"87678_CR7","doi-asserted-by":"crossref","unstructured":"Buttiron Webber, T., Briata, I. M., DeCensi, A., Cevasco, I. & Paleari, L. Taste and smell disorders in cancer treatment: Results from an integrative rapid systematic review. Int. J. Mol. Sci. 28 ;24(3). (2023).","DOI":"10.3390\/ijms24032538"},{"key":"87678_CR8","doi-asserted-by":"publisher","first-page":"1268672","DOI":"10.3389\/fonc.2023.1268672","volume":"13","author":"MA Barbieri","year":"2023","unstructured":"Barbieri, M. A. et al. Neuropsychiatric adverse drug reactions with oral tyrosine kinase inhibitors in metastatic colorectal cancer: An analysis from the FDA adverse event reporting system. Front. Oncol. 13, 1268672 (2023). Published 2023 Oct 31.","journal-title":"Front. Oncol."},{"issue":"3","key":"87678_CR9","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1007\/s00520-021-06658-z","volume":"30","author":"JM van Elst","year":"2022","unstructured":"van Elst, J. M. et al. Taste, smell and mouthfeel disturbances in patients with gastrointestinal stromal tumors treated with tyrosine-kinase inhibitors. Support. Care Cancer. 30 (3), 2307\u20132315 (2022).","journal-title":"Support Care Cancer"},{"key":"87678_CR10","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ejca.2017.09.006","volume":"86","author":"A van der Werf","year":"2017","unstructured":"van der Werf, A., Rovithi, M., Langius, J. A. E., de van der Schueren, M. A. E. & Verheul, H. M. W. Insight in taste alterations during treatment with protein kinase inhibitors. Eur. J. Cancer. 86, 125\u2013134 (2017).","journal-title":"Eur. J. Cancer"},{"issue":"7","key":"87678_CR11","doi-asserted-by":"publisher","first-page":"796","DOI":"10.7150\/ijms.6048","volume":"10","author":"T Sakaeda","year":"2013","unstructured":"Sakaeda, T., Tamon, A., Kadoyama, K. & Okuno, Y. Data mining of the public version of the FDA adverse event reporting system. Int. J. Med. Sci. 10 (7), 796\u2013803 (2013).","journal-title":"Int. J. Med. Sci."},{"issue":"8","key":"87678_CR12","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s40264-013-0075-1","volume":"36","author":"J Slattery","year":"2013","unstructured":"Slattery, J., Alvarez, Y. & Hidalgo, A. Choosing thresholds for statistical signal detection with the proportional reporting ratio. Drug Saf. 36 (8), 687\u2013692 (2013).","journal-title":"Drug Saf. Aug"},{"key":"87678_CR13","doi-asserted-by":"publisher","first-page":"116919","DOI":"10.1016\/j.bone.2023.116919","volume":"177","author":"LH Ji","year":"2023","unstructured":"Ji, L. H., Zhao, C. L., Wang, Y. Q. & Fu, Z. H. Bisphosphonates-related tendinopathies and ligament disorders: Cases analysis from the U.S. Food and Drug Administration adverse event reporting system. Bone 177, 116919 (2023).","journal-title":"Bone"},{"issue":"7\u20138","key":"87678_CR14","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.drudis.2008.12.012","volume":"14","author":"M Hauben","year":"2009","unstructured":"Hauben, M. & Bate, A. Decision support methods for the detection of adverse events in post-marketing data. Drug Discov. Today. 14 (7\u20138), 343\u2013357 (2009).","journal-title":"Drug Discovery Today Apr"},{"issue":"6","key":"87678_CR15","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/clpt.2013.24","volume":"93","author":"R Harpaz","year":"2013","unstructured":"Harpaz, R. et al. Performance of pharmacovigilance signal-detection algorithms for the FDA adverse event reporting system. Clin. Pharmacol. Ther. 93 (6), 539\u2013546 (2013).","journal-title":"Clin. Pharmacol. Ther."},{"key":"87678_CR16","doi-asserted-by":"crossref","unstructured":"Naimi, B. R. et al. Patient insights into the diagnosis of smell and taste disorders in the United States. Preprint medRxiv (2023). 2023.09.20.23295861.","DOI":"10.1101\/2023.09.20.23295861"},{"issue":"8","key":"87678_CR17","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1002\/lary.26558","volume":"127","author":"GS Ajmani","year":"2017","unstructured":"Ajmani, G. S., Suh, H. H., Wroblewski, K. E. & Pinto, J. M. Smoking and olfactory dysfunction: A systematic literature review and meta-analysis. Laryngoscope 127 (8), 1753\u20131761 (2017).","journal-title":"Laryngoscope"},{"key":"87678_CR18","unstructured":"Agarwal, K., Schaffe-Odeleye, T., Marzouk, M. & Joseph, P. V. Reduced bitter taste and enhanced appetitive odor identification in individuals at risk for alcohol use disorder: National Health and Nutrition Examination Survey (NHANES) 2013\u20132014. J Stud Alcohol Drugs."},{"issue":"5","key":"87678_CR19","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s40265-021-01487-0","volume":"81","author":"YN Lamb","year":"2021","unstructured":"Lamb, Y. N. & Nintedanib A review in Fibrotic interstitial lung diseases. Drugs Apr. 81 (5), 575\u2013586 (2021).","journal-title":"Drugs Apr"},{"issue":"1","key":"87678_CR20","doi-asserted-by":"publisher","first-page":"e2021869","DOI":"10.1001\/jamanetworkopen.2020.21869","volume":"4","author":"S Dudani","year":"2021","unstructured":"Dudani, S. et al. Evaluation of clear cell, papillary, and chromophobe renal cell carcinoma metastasis sites and association with survival. JAMA Netw. Open. 4 (1), e2021869 (2021).","journal-title":"JAMA Netw. open. Jan"},{"key":"87678_CR21","doi-asserted-by":"crossref","unstructured":"Zheng, Q. et al. Mortality and survival in idiopathic pulmonary fibrosis: A systematic review and meta-analysis. ERJ Open. Res. 8(1). (2022).","DOI":"10.1183\/23120541.00591-2021"},{"issue":"9","key":"87678_CR22","doi-asserted-by":"publisher","first-page":"e2435066","DOI":"10.1001\/jamanetworkopen.2024.35066","volume":"7","author":"M Yilma","year":"2024","unstructured":"Yilma, M. et al. Survival outcomes among patients with Hepatocellular Carcinoma in a large Integrated US Health System. JAMA Netw. Open. 7 (9), e2435066 (2024).","journal-title":"JAMA Netw. Open."},{"issue":"12","key":"87678_CR23","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1001\/jama.2024.12848","volume":"332","author":"TL Rose","year":"2024","unstructured":"Rose, T. L. & Kim, W. Y. Renal cell carcinoma: A review. JAMA 332 (12), 1001\u20131010 (2024).","journal-title":"JAMA"},{"issue":"1","key":"87678_CR24","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1634\/theoncologist.2011-0111","volume":"17","author":"CB Boers-Doets","year":"2012","unstructured":"Boers-Doets, C. B. et al. Oral adverse events associated with tyrosine kinase and mammalian target of rapamycin inhibitors in renal cell carcinoma: A structured literature review. Oncologist 17 (1), 135\u2013144 (2012).","journal-title":"Oncologist"},{"issue":"2","key":"87678_CR25","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.oraloncology.2009.11.008","volume":"46","author":"JB Epstein","year":"2010","unstructured":"Epstein, J. B. & Barasch, A. Taste disorders in cancer patients: Pathogenesis, and approach to assessment and management. Oral Oncol. 46 (2), 77\u201381 (2010).","journal-title":"Oral Oncol."},{"issue":"5","key":"87678_CR26","first-page":"552","volume":"1","author":"X Zheng","year":"2018","unstructured":"Zheng, X. et al. [Development and homeostasis of taste buds in mammals]. Hua Xi Kou Qiang Yi Xue Za Zhi\u2009=\u2009Huaxi Kouqiang Yixue Zazhi\u2009=\u2009West. China J. Stomatol. 1 (5), 552\u2013558 (2018).","journal-title":"China J. Stomatology Oct."},{"issue":"2","key":"87678_CR27","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1136\/bjo.2008.141580","volume":"93","author":"S Kanayama","year":"2009","unstructured":"Kanayama, S. et al. Analysis of soluble vascular endothelial growth factor receptor-1 secreted from cultured corneal and oral mucosal epithelial cell sheets in vitro. Br. J. Ophthalmol.. 93 (2), 263\u2013267 (2009).","journal-title":"Br. J. Ophthalmol. Feb"},{"issue":"6","key":"87678_CR28","first-page":"1585","volume":"28","author":"Y Katoh","year":"2006","unstructured":"Katoh, Y. & Katoh, M. Comparative integromics on VEGF family members. Int. J. Oncol. 28 (6), 1585\u20131589 (2006).","journal-title":"Int. J. Oncol. Jun"},{"issue":"24","key":"87678_CR29","doi-asserted-by":"publisher","first-page":"7529","DOI":"10.1158\/1078-0432.CCR-09-0336","volume":"15","author":"S Naik","year":"2009","unstructured":"Naik, S., Dothager, R. S., Marasa, J., Lewis, C. L. & Piwnica-Worms, D. Vascular endothelial growth factor Receptor-1 is synthetic Lethal to aberrant beta-catenin activation in Colon cancer. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 15 (24), 7529\u20137537 (2009).","journal-title":"Clin. cancer Research: Official J. Am. Association Cancer Res. Dec."},{"issue":"10","key":"87678_CR30","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1007\/s00018-013-1283-7","volume":"70","author":"P Carmeliet","year":"2013","unstructured":"Carmeliet, P. & Ruiz de Almodovar, C. VEGF ligands and receptors: Implications in neurodevelopment and neurodegeneration. Cell. Mol. Life Sci. CMLS. 70 (10), 1763\u20131778 (2013).","journal-title":"Cell. Mol. life Sciences: CMLS May"},{"issue":"1","key":"87678_CR31","first-page":"318","volume":"25","author":"H Wang","year":"2023","unstructured":"Wang, H., Deng, L. & Qin, X. [Development of an olfactory epithelial organoid culture system based on small molecule screening]. Sheng Wu gong. Cheng Xue bao = Chin. J. Biotechnol.. 25 (1), 318\u2013336 (2023).","journal-title":"Sheng Wu gong. Cheng Xue bao = Chin. J. Biotechnol. Jan"},{"issue":"6","key":"87678_CR32","doi-asserted-by":"publisher","first-page":"606","DOI":"10.2500\/ajr.2008.22.3238","volume":"22","author":"AP Wu","year":"2008","unstructured":"Wu, A. P. & Davidson, T. Posttraumatic anosmia secondary to central nervous system injury. Am. J. Rhinol. 22 (6), 606\u2013607 (2008).","journal-title":"Am. J. Rhinology Nov-Dec"},{"issue":"16","key":"87678_CR33","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1001\/jama.1997.03550160077042","volume":"22\u201329","author":"SS Schiffman","year":"1997","unstructured":"Schiffman, S. S. Taste and smell losses in normal aging and disease. Jama 22\u201329 (16), 1357\u20131362 (1997).","journal-title":"Jama Oct."},{"issue":"18","key":"87678_CR34","doi-asserted-by":"publisher","first-page":"11946","DOI":"10.1073\/pnas.182296499","volume":"3","author":"K Jin","year":"2002","unstructured":"Jin, K. et al. Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo. Proc. Natl. Acad. Sci. U. S. A. 3 (18), 11946\u201311950 (2002).","journal-title":"Proc. Natl. Acad. Sci. United States Am. Sep."},{"issue":"27","key":"87678_CR35","doi-asserted-by":"publisher","first-page":"8704","DOI":"10.1523\/JNEUROSCI.5527-08.2009","volume":"8","author":"IM Wittko","year":"2009","unstructured":"Wittko, I. M. et al. VEGFR-1 regulates adult olfactory bulb neurogenesis and migration of neural progenitors in the rostral migratory stream in vivo. J. Neurosci. Off. J. Soc. Neurosci.. 8 (27), 8704\u20138714 (2009).","journal-title":"J. Neuroscience: Official J. Soc. Neurosci. Jul"},{"issue":"3","key":"87678_CR36","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.neuroscience.2004.11.056","volume":"132","author":"P Mohapel","year":"2005","unstructured":"Mohapel, P., Frielingsdorf, H., Haggblad, J., Zachrisson, O. & Brundin, P. Platelet-derived growth factor (PDGF-BB) and brain-derived neurotrophic factor (BDNF) induce striatal neurogenesis in adult rats with 6-hydroxydopamine lesions. Neuroscience 132 (3), 767\u2013776 (2005).","journal-title":"Neuroscience"},{"issue":"10","key":"87678_CR37","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.4103\/1673-5374.238713","volume":"13","author":"K Beecher","year":"2018","unstructured":"Beecher, K., Hafner, L. M., Ekberg, J., St John, J. A. & Chehrehasa, F. Combined VEGF\/PDGF improves olfactory regeneration after unilateral bulbectomy in mice. Neural Regen. Res. 13 (10), 1820\u20131826 (2018).","journal-title":"Neural Regeneration Res. Oct."},{"issue":"2","key":"87678_CR38","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.yexcr.2005.03.027","volume":"306","author":"CL Beites","year":"2005","unstructured":"Beites, C. L., Kawauchi, S., Crocker, C. E. & Calof, A. L. Identification and molecular regulation of neural stem cells in the olfactory epithelium. Exp. Cell. Res. 306 (2), 309\u2013316 (2005).","journal-title":"Exp. Cell. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87678-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87678-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87678-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T14:19:40Z","timestamp":1737728380000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87678-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,24]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["87678"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-87678-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,24]]},"assertion":[{"value":"23 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3118"}}